Journal Mobile Options
Table of Contents
Vol. 25, No. 3, 2007
Issue release date: September 2007
Section title: Small Bowel
Dig Dis 2007;25:237–240

Small Intestinal Bacterial Overgrowth: Diagnosis and Treatment

Gasbarrini A. · Lauritano E.C. · Gabrielli M. · Scarpellini E. · Lupascu A. · Ojetti V. · Gasbarrini G.
Internal Medicine Department, Gemelli Hospital, Catholic University of Sacred Heart, Rome, Italy
email Corresponding Author

Prof. Antonio Gasbarrini

Internal Medicine Department, Catholic University of Sacred Heart

Gemelli Hospital, Largo A. Gemelli, 8

IT–00168 Rome (Italy)

Tel. +39 06 3015 4294, Fax +39 06 3550 2775, E-Mail


  1. Luckey TD: Introduction to intestinal microecology. Am J Clin Nutr 1972;25:1292–1294.
  2. Hooper LV, Midtvedt T, Gordon JI: How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002;22:283–307.
  3. Donaldson RM Jr: Normal bacterial population of the intestine and their relation to intestinal function. N Engl J Med 1964;270:938–945.
  4. Nucera G, Gabrielli M, Lupascu A, Lauritano EC, Santoliquido A, Cremonini F, Cammarota G, Tondi P, Pola P, Gasbarrini G, Gasbarrini A: Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391–1395.
  5. Varcoe R, Haliday D, Tavill AS: Utilization of urea nitrogen for albumin synthesis in the stagnant loop syndrome: Gut 1974;15:898–902.
  6. Wanitschke R, Ammon HV: Effects of dihydroxy bile acids and hydroxy fatty acids on the absorption of oleic acid in the human jejunum. J Clin Invest 1978;61:178–186.
  7. Saltzman JR, Kowdley KV, Pedrosa MC, Sepe T, Golner B, Perrone G, Russell RM: Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology 1994;106:615–623.
  8. Lin EC: Small intestinal bacterial overgrowth, a framework for understanding irritable bowel syndrome. JAMA 2004;292:852–858.
  9. Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, Flore R, Tondi P, Pola P, Gasbarrini G, Gasbarrini A: Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157–1160.
  10. Corazza GR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, Lecchini R, Avanzini P, Chezzi C, Gasbarrini G: The diagnosis of small bowel bacterial overgrowth. Gastroenterology 1990;98:302–309.
  11. Romagnuolo J, Schiller D, Bailey RJ: Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002;97:1113–1126.
  12. Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza GR: Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2000;14:551–556.
  13. Di Stefano M, Miceli E, Missanelli A, Mazzochi S, Corazza GR: Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther 2005;21:985–992.
  14. Attar A, Flourie B, Rambaud JC, Franchisseur C, Ruszniewski P, Bouhnik Y: Antibiotic efficacy in small intestinal bacterial overgrowth related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999;117:794–797.
  15. Castiglione F, Rispo A, Di Girolamo E, Cozzolino A, Manguso F, Grassia R, Mazzacca G: Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn’s disease. Aliment Pharmacol Ther 2003;18:1107–1112.
  16. Scarpignato C, Pelosini I: Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic. Digestion 2006;73(suppl 1):13–27.
  17. Lauritano EC, Gabrielli M, Lupascu A, Santoliquido A, Nucera G, Scarpellini E, Vincenti F, Cammarota G, Flore R, Pola P, Gasbarrini G, Gasbarrini A: Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;22:31–35.
  18. Cuoco L, Salvagnini M: Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol Dietol 2006;52:89–95.
  19. Pimentel M, Chow EJ, Lin HC: Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98:412–419.